http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2041949-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ac831e443ec1da5c5476b2460b57606 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 |
| filingDate | 1993-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1057e423df48b0b79d24bbed0246615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f3887e431d23bdc998282bb35afe75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007ab3515c5a8fa48c8c5f95b573d35a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14d78e227d58bd70826b365b052ce968 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9caaab0737b160d41e690b39608ba5c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4afa4142b025a828bca09356826d5078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c80b31165b435280e5de61ecac966d33 |
| publicationDate | 1995-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2041949-C1 |
| titleOfInvention | Hc356 deoxyribonucleic acid segment, polypeptide, escherichia coli strain as producer of polypeptide capable of binding hepatitis c virus antibodies |
| abstract | FIELD: biological engineering. SUBSTANCE: polypeptides possessing properties of hepatitis C virus internal antigen are obtained. The polypeptides are capable of binding antibodies to hepatitis C virus Cor-antigen. After having been administered to experimental animals, the polypeptides invoke formation of specific antibodies to hepatitis C virus Cor-antigen. The polypeptides are synthesized by Escherichia coli bacterial strain produced by transforming PLT90 strain with pH 365 F recombinant plasmids possessing nucleotide sequence of Escherichia coli Cor-antigen gen. EFFECT: enhanced effectiveness in detecting hepatitis C virus antibodies and producing specific antibodies. 3 cl |
| priorityDate | 1993-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.